AGYWX
Price
$60.59
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
RGAGX
Price
$77.25
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

AGYWX vs RGAGX

Header iconAGYWX vs RGAGX Comparison
Open Charts AGYWX vs RGAGXBanner chart's image
American Century Growth Y
Price$60.59
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R6
Price$77.25
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
AGYWX vs RGAGX Comparison Chart
Loading...
VS
AGYWX vs. RGAGX commentary
Sep 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGYWX is a Buy and RGAGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 284B vs. AGYWX (15.4B). RGAGX pays higher dividends than AGYWX: RGAGX (0.75) vs AGYWX (0.00). AGYWX was incepted earlier than RGAGX: AGYWX (7 years) vs RGAGX (15 years). RGAGX is a more actively managed with annual turnover of: 31.00 vs. AGYWX (20.00). AGYWX has a lower initial minimum investment than RGAGX: AGYWX (0) vs RGAGX (250). AGYWX (24.39) and RGAGX (24.16) have marching annual gain over last year. AGYWX return over 5 years is better than : 65.50 vs. RGAGX (52.01).
AGYWXRGAGXAGYWX / RGAGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years15 years-
Gain YTD17.38419.58689%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets15.4B284B5%
Annual Yield % from dividends0.000.75-
Returns for 1 year24.3924.16101%
Returns for 3 years3.47-2.53-137%
Returns for 5 years65.5052.01126%
Returns for 10 yearsN/A64.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSG17.550.68
+4.03%
Inseego Corp
STRL134.944.59
+3.52%
Sterling Infrastructure
CMI300.65-0.94
-0.31%
Cummins
GENI7.65-0.26
-3.29%
Genius Sports Limited
EPIX6.05-0.72
-10.64%
ESSA Pharma